CRISPR–Cas based platforms for RNA detection: fundamentals and applications
Chemical Communications · 2025 · 61 (72) · 13571-13600
DOI: 10.1039/d5cc03257a ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Communications, 2025. Verfasst von Mahsa Bagi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27605, USA. qwei3@ncsu.edu. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, RNA. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 225 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Science Foundation.
Abstract (Originalsprache)
CRISPR-Cas technologies are turning into new RNA detection platforms for diagnosing many urgent diseases such as infections and cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, NC 27605, USA. qwei3@ncsu.edu.
Förderung
- National Science Foundation
Zitieren
APA
Bagi, M., Jamalzadegan, S., Steksova, A., & Wei, Q. (2025). CRISPR–Cas based platforms for RNA detection: fundamentals and applications. Chemical Communications, 61(72), 13571-13600. https://doi.org/10.1039/d5cc03257a
Vancouver
Bagi M, Jamalzadegan S, Steksova A, Wei Q. CRISPR–Cas based platforms for RNA detection: fundamentals and applications. Chemical Communications. 2025;61(72):13571-13600. doi:10.1039/d5cc03257a
BibTeX
@article{Bagi2025,
author = {Bagi, Mahsa and Jamalzadegan, Sina and Steksova, Anastasiia and Wei, Qingshan},
title = {CRISPR–Cas based platforms for RNA detection: fundamentals and applications},
journal = {Chemical Communications},
year = {2025},
volume = {61},
number = {72},
pages = {13571--13600},
doi = {10.1039/d5cc03257a}
}
EUVIMED